Article

Study Reveals Potential New Test for Early Osteoarthritis Detection

Scientists have discovered new methods for measuring biological markers in the blood, which can be used according to diagnose osteoarthritis earlier, according to a public release from King's College London's Department if Twin Research and Genetic Epidemiology.

Researchers were able to test for 163 chemical signals "from a single blood sample,” by using the new method called metabolomics. “These chemical signals are intermediate products of the metabolism of human cells and their 26,000 metabolite ratios represent the rate of the chemical reactions in the human body."

“The team studied 123 white women with osteoarthritis of the knee and 299 healthy women. The researchers compared the difference in the metabolites and the 26,000 metabolite ratios between the two groups. They found 14 metabolite ratios were significantly associated with osteoarthritis. The team then tested these signals to see if they were replicated in an independent sample consisting of 76 women with knee arthritis and 100 healthy women. Two ratios — valine to histidine and xleucine to histidine – were successfully confirmed in the replication sample.”

Researcher Dr. Guangju Zhai said, in a press release, the discovery of the two biomarkers is a “hugely exciting area of clinical research.” The two biomarkers “could indicate increased cartilage breakdown,” he said.

Annals of Rheumatic Disease

The study results were published in the journal, .

Scientists have discovered a new method for measuring biological markers in blood, which can be used to diagnose osteoarthritis earlier, according to a public release from King’s College London’s Department of Twin Research and Genetic Epidemiology.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.